DiscoveryPak™ EGFR Tyrosine Kinase Inhibitor Set for cell activation

A convenient set consisting of five Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase (TK) inhibitors. The five inhibitors are: 5 mg of Canertinib (Cat. No. 1617-5), 100 mg of Erlotinib, Hydrochloride (Cat. No. 1588-100), 5 mg of Gefitinib (Cat. No. 1589-5), 25 mg of Lapatinib, Ditosylate (Cat. No. 1624-25), and 2 mg of PD 153035 Hydrochloride (Cat. No. 1656-2).

N/A

See under the individual product

See under the individual product

Biochemicals

EGFR Tyrosine Kinase Inhibitor Set, DiscoveryPak™

See under the individual product

Lyophilized solids

N/A

No

Yes

≥95% by HPLC

DMSO

-20°C

gel pack

24 months

Protect from air, light and moisture

cell, set

For cells, cell lines and tissues in culture till half confluency.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.